Hepato-preferential insulins: Is this the end, or the end of the beginning?

Russell-Jones D. L.

首页> 外文期刊>Diabetes, obesity & metabolism >Hepato-preferential insulins: Is this the end, or the end of the beginning?

【24h】

Hepato-preferential insulins: Is this the end, or the end of the beginning?

机译：肝优先胰岛素：这是终点还是起点？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes, obesity & metabolism》 |2016年第11期|共2页
作者
Russell-Jones D. L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of hepato-preferential basal insulin peglispro on nuclear magnetic resonance biomarkers lipoprotein insulin resistance index and GlycA in patients with diabetes [J] . Connelly Margery A., Otvos James D., Zhang Qianyi, Biomarkers in medicine . 2017,第11期

机译：Hepato优先基底胰岛素PEGLISPRO对糖尿病患者核磁共振生物标志物对核磁共振生物标志物脂蛋白胰岛素抗性指数和糖粉的影响
2. Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog [J] . Dale S. Edgerton, Mary C. Moore, Jason J. Winnick, Diabetes . 2014,第11期

机译：响应于肝优先胰岛素类似物的给药，葡萄糖和脂肪代谢的变化
3. Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-na?ve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study [J] . Seiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, Endocrine journal . 2019,第8期

机译：胰岛素-NA've日本成年人患有2型糖尿病的胰岛素-NA've日本成年人的疗效和安全性的疗效和安全性的疗效和安全性和胰岛素的疗效和安全性和胰岛素的疗效和安全性：飞行员，随机，受控研究
4. Insulin Degludec, Insulin Glargine U300, and Other Novel Insulin Formulations [C] . American College of Veterinary Internal Medicine Forum Conference . 2018

机译：胰岛素Degludec，胰岛素甘氨酸U300等新型胰岛素配方
5. Evaluating Hypoglycemic Risk of Two Basal Insulin Delivery Methods for Type 1 Diabetes: A Comparison of Tresiba Insulin Against Continuous Subcutaneous Insulin Infusion Using Data from Continuous Glucose Monitors [D] . Lane, Benjamin. 2020

机译：评估1型糖尿病两种基础胰岛素递送方法的低血糖风险：使用来自连续葡萄糖监测器的数据进行TRESIBA胰岛素对连续皮下胰岛素输注的比较
6. Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog [O] . Dale S. Edgerton, Mary C. Moore, Jason J. Winnick, 2014

机译：响应于肝优先胰岛素类似物的给药葡萄糖和脂肪代谢的变化
7. Protamine-containing insulin but not analog insulin and duration of insulin use are risk factors for the production of insulin autoantibodies in insulin-treated patients with diabetes mellitus [O] . Hidenao Nishimura, Katsumi Iizuka, Jun Takeda 2014

机译：含protamine的胰岛素但不是模拟胰岛素和胰岛素的持续时间使用是生产胰岛素治疗糖尿病患者胰岛素自身抗体的危险因素

Hepato-preferential insulins: Is this the end, or the end of the beginning?

著录项

相似文献

相关主题

期刊订阅